Literature DB >> 11415465

Glycopeptide N-acetylgalactosaminyltransferase specificities for O-glycosylated sites on MUC5AC mucin motif peptides.

D Tetaert1, K G Ten Hagen, C Richet, A Boersma, J Gagnon, P Degand.   

Abstract

The recombinant proteins of the two novel UDP-N-acetylgalactosamine (GalNAc) glycopeptide:N-acetylgalactosaminyltransferases (designated gpGaNTase-T7 and gpGaNTase-T9) were assayed with O-glycosylated products obtained from the prior action of the ubiquitous transferases (GaNTase-T1 and GaNTase-T2) towards MUC5AC mucin motif peptides (GTTPSPVPTTSTTSAP and peptides with single amino acid substitutions, GTTPSAVPTTSTTSVP and GTTPSPVPTTSITSVP, that are a reflection of mucin molecule polymorphism). gpGaNTase-T9 is known to be expressed differentially and more abundantly than gpGaNTase-T7 in some tissues; the results of in vitro glycosylation also indicates a difference in acceptor substrate specificities between the gpGaNTase isoforms. With the use of capillary electrophoresis, MS and Edman degradation, our study suggests that, in the O-glycosylation of mucin-type proteins, approach and recognition signalling by gpGaNTase-T7 and gpGaNTase-T9 depend largely on the peptide's primary structure (for example the presence of multiple clusters of hydroxy amino acids and the number of GalNAc residues attached to the peptide backbone). O-glycosylation in terms of sites of attachment seems to be less random than previously described and, if sequential reactions are ordered throughout the Golgi stack, the complete O-glycosylation of the mucin molecules seems to be finely tuned to respond to specific damage to, or attack on, epithelia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415465      PMCID: PMC1221957          DOI: 10.1042/0264-6021:3570313

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Structure-function analysis of the UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. Essential residues lie in a predicted active site cleft resembling a lactose repressor fold.

Authors:  F K Hagen; B Hazes; R Raffo; D deSa; L A Tabak
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family.

Authors:  K G Ten Hagen; F K Hagen; M M Balys; T M Beres; B Van Wuyckhuyse; L A Tabak
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

Review 3.  The acceptor specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases.

Authors:  A P Elhammer; F J Kézdy; A Kurosaka
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

4.  The AATPAP sequence is a very efficient signal for O-glycosylation in CHO cells.

Authors:  M Asada; N Orikasa; A Yoneda; Y Oda; K Ota; T Imamura
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

5.  A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.

Authors:  E P Bennett; H Hassan; M A Hollingsworth; H Clausen
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

6.  Capillary zone electrophoresis and MALDI-mass spectrometry for the monitoring of in vitro O-glycosylation of a threonine/serine-rich MUC5AC hexadecapeptide.

Authors:  B Soudan; S Hennebicq; D Tetaert; A Boersma; C Richet; D Demeyer; G Briand; P Degand
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-06-11

7.  Characterization of a UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase that displays glycopeptide N-acetylgalactosaminyltransferase activity.

Authors:  K G Ten Hagen; D Tetaert; F K Hagen; C Richet; T M Beres; J Gagnon; M M Balys; B VanWuyckhuyse; G S Bedi; P Degand; L A Tabak
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

8.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  Molecular cloning of a novel human UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T8, and analysis as a candidate autosomal dominant hypophosphatemic rickets (ADHR) gene.

Authors:  K E White; B Lorenz; W E Evans; T Meitinger; T M Strom; M J Econs
Journal:  Gene       Date:  2000-04-04       Impact factor: 3.688

10.  Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.

Authors:  E P Bennett; H Hassan; U Mandel; E Mirgorodskaya; P Roepstorff; J Burchell; J Taylor-Papadimitriou; M A Hollingsworth; G Merkx; A G van Kessel; H Eiberg; R Steffensen; H Clausen
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

View more
  8 in total

1.  UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.

Authors:  Jayalakshmi Raman; Yu Guan; Cynthia L Perrine; Thomas A Gerken; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-20       Impact factor: 4.313

Review 2.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

3.  The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1.

Authors:  Timothy A Fritz; James H Hurley; Loc-Ba Trinh; Joseph Shiloach; Lawrence A Tabak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-14       Impact factor: 11.205

4.  The catalytic and lectin domains of UDP-GalNAc:polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection.

Authors:  Jayalakshmi Raman; Timothy A Fritz; Thomas A Gerken; Oliver Jamison; David Live; Mian Liu; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

Review 5.  Recent insights into the biological roles of mucin-type O-glycosylation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  Glycoconj J       Date:  2008-08-10       Impact factor: 2.916

6.  The expression of human FUT1 in HT-29/M3 colon cancer cells instructs the glycosylation of MUC1 and MUC5AC apomucins.

Authors:  Anna López-Ferrer; Carme de Bolós
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

7.  COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity.

Authors:  Isao Kurihara; Dong-Kee Lee; Fabrice G Petit; Jaewook Jeong; Kevin Lee; John P Lydon; Francesco J DeMayo; Ming-Jer Tsai; Sophia Y Tsai
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917

8.  High level in vivo mucin-type glycosylation in Escherichia coli.

Authors:  Phillipp Mueller; Rahul Gauttam; Nadja Raab; René Handrick; Claudia Wahl; Sebastian Leptihn; Michael Zorn; Michaela Kussmaul; Marianne Scheffold; Bernhard Eikmanns; Lothar Elling; Sabine Gaisser
Journal:  Microb Cell Fact       Date:  2018-10-26       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.